These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1938701)

  • 41. Prospective evaluation of a vancomycin dosage guideline for neonates.
    Gabriel MH; Kildoo GC; Gennrich JL; Modanlou HD; Collins SR
    Clin Pharm; 1991 Feb; 10(2):129-32. PubMed ID: 2009729
    [No Abstract]   [Full Text] [Related]  

  • 42. What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?
    Tattevin P; Camus C
    Clin Infect Dis; 2006 Jun; 42(12):1813-4; author reply 1814-5. PubMed ID: 16705599
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of vancomycin dosing protocols to achieve therapeutic serum concentrations in patients receiving high-flux haemodialysis.
    Lin SY; Shen MC; Hwang SJ; Chen YH; Chen TC; Chiu YW; Lu PL
    Int J Antimicrob Agents; 2014 Apr; 43(4):384-5. PubMed ID: 24556550
    [No Abstract]   [Full Text] [Related]  

  • 45. Vancomycin dosing.
    Ebell MH
    J Fam Pract; 1994 May; 38(5):526-7. PubMed ID: 8195725
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction.
    Spadaro S; Berselli A; Fogagnolo A; Capuzzo M; Ragazzi R; Marangoni E; Bertacchini S; Volta CA
    BMC Anesthesiol; 2015 Jun; 15():95. PubMed ID: 26116239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Why monitor peak vancomycin concentrations?
    Collyns TA; Oppenheim BA
    Lancet; 1995 Mar; 345(8950):645; author reply 646-7. PubMed ID: 7898190
    [No Abstract]   [Full Text] [Related]  

  • 48. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
    Oudin C; Vialet R; Boulamery A; Martin C; Simon N
    Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapeutic monitoring of vancomycin in routine clinical practice].
    Kacířová I; Grundmann M
    Vnitr Lek; 2014 Oct; 60(10):846-51. PubMed ID: 25382007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial dosing of vancomycin in critically ill patients.
    Kees MG; Vögeler S; Hilpert JW
    Int J Antimicrob Agents; 2011 Jul; 38(1):91-2. PubMed ID: 21546217
    [No Abstract]   [Full Text] [Related]  

  • 51. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital in Singapore.
    Seng JJB; Yong MHA; Peh ZX; Soong JL; Tan MH
    Int J Clin Pharm; 2018 Oct; 40(5):977-981. PubMed ID: 29948742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Creatinine Clearance Estimations for Vancomycin Maintenance Dose Adjustments.
    Šíma M; Hartinger J; Štenglová Netíková I; Slanař O
    Am J Ther; 2018; 25(5):e602-e604. PubMed ID: 28650911
    [No Abstract]   [Full Text] [Related]  

  • 54. Vancomycin: the need to suit serum concentrations in hemodialysis patients.
    Marengo LL; Del Fiol Fde S; Oliveira Sde J; Nakagawa C; Croco EL; Barberato-Filho S; Peçanha MP; Silva DF; Toledo MI
    Braz J Infect Dis; 2010; 14(2):203-8. PubMed ID: 20563453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Why monitor peak vancomycin concentrations?
    Wysocki M; Thomas F; Wolff M
    Lancet; 1995 Mar; 345(8950):646; author reply 646-7. PubMed ID: 7898194
    [No Abstract]   [Full Text] [Related]  

  • 56. Why monitor peak vancomycin concentrations?
    Duffull SB; Begg EJ
    Lancet; 1995 Mar; 345(8950):646; author reply 646-7. PubMed ID: 7898193
    [No Abstract]   [Full Text] [Related]  

  • 57. A randomized trial of loading vancomycin in the emergency department.
    Rosini JM; Laughner J; Levine BJ; Papas MA; Reinhardt JF; Jasani NB
    Ann Pharmacother; 2015 Jan; 49(1):6-13. PubMed ID: 25358330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine monitoring of serum vancomycin concentrations: can waiting be justified?
    Rodvold KA; Zokufa H; Rotschafer JC
    Clin Pharm; 1987 Aug; 6(8):655-8. PubMed ID: 3691014
    [No Abstract]   [Full Text] [Related]  

  • 59. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    Matsumoto K; Takesue Y; Ohmagari N; Mochizuki T; Mikamo H; Seki M; Takakura S; Tokimatsu I; Takahashi Y; Kasahara K; Okada K; Igarashi M; Kobayashi M; Hamada Y; Kimura M; Nishi Y; Tanigawara Y; Kimura T
    J Infect Chemother; 2013 Jun; 19(3):365-80. PubMed ID: 23673472
    [No Abstract]   [Full Text] [Related]  

  • 60. Vancomycin concentrations associated with red-top and serum-separator collection.
    Dybala M; Gilliland K
    Am J Health Syst Pharm; 2002 Jan; 59(2):196. PubMed ID: 11826572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.